Precise Regulation of Inflammation and Oxidative Stress by ROS‐Responsive Prodrug Coated Balloon for Preventing Vascular Restenosis

• Published in: Advanced functional materials 2023-07, Vol.33 (30), p.n/a
• Main Authors: Zhao, Jing, Fu, Jia‐yin, Jia, Fan, Li, Jian, Yu, Bo, Huang, Yue, Ren, Ke‐feng, Ji, Jian, Fu, Guo‐sheng
• Format: Article
• Language: English
• Subjects: antioxidation; anti‐inflammation; Aorta; balloon coating; Endothelium; Hyperplasia; Inflammation; Materials science; MicroRNAs; Oxidative stress; Ribonucleic acid; RNA; ROS‐responsive/scavenging; Scavenging; vascular restenosis
• ISSN: 1616-301X; 1616-3028
• DOI: 10.1002/adfm.202213993

Vascular restenosis after balloon dilation is largely caused by the over‐proliferation of smooth muscle cells, which is triggered and exacerbated by local excessive inflammation and oxidative stress. The excessive inflammatory and oxidative stress cause tissue/cell damage, hamper endothelial functions, and worsen intimal hyperplasia and restenosis. A high level of reactive oxygen species (ROS) overproduction is regarded as the main culprit. Therefore, efficiently inhibiting ROS over‐production or weightily depleting them is of great significance. Herein, a “ROS‐responsive/scavenging prodrug” is introduced into balloon coating for the treatment of vascular restenosis. A reversible phenylboronic ester‐bearing caffeic acid (CA) macromolecular prodrug (PBC) is designed for the controlled and on‐demand dual‐drug release triggered by the local high ROS level; the released CA and 4‐hydroxybenzyl alcohol exhibit efficient antioxidant and anti‐inflammatory effects by scavenging ROS, thereby regulating vascular microenvironment and protecting endothelium functions. To accelerate endothelium regeneration, pro‐endothelial microRNA‐126 is further introduced. The ROS‐responsive/scavenging prodrug/miRNA balloon coating efficiently prevents intimal hyperplasia, alleviates local inflammation, and improves endothelium healing in a rat abdominal aorta restenosis model, which may provide applicative perspectives for next‐generation drug‐coated balloons and other cardiovascular diseases treatment. A reversible phenylboronic ester‐bearing caffeic acid (CA) macromolecular prodrug (PBC) is designed for the controlled and on‐demand dual‐antioxidant release (CA and 4‐hydroxybenzyl alcohol (HBA)) triggered by the local high reactive oxygen species (ROS) level, thereby exhibiting antioxidant and anti‐inflammatory effects; the pro‐endothelial microRNA‐126 is introduced to further accelerate endothelialization. This ROS‐responsive/scavenging prodrug/miRNA balloon coating efficiently inhibits long‐term vascular restenosis.